Homocystinuria
Autosomal-recessive cystathionine β-synthase deficiency
Overview
Autosomal-recessive deficiency of cystathionine β-synthase, causing homocysteine accumulation. A Marfan-like phenotype (tall, long limbs, lens dislocation) but with intellectual disability and, crucially, a strong thrombotic tendency. The lens dislocates DOWNWARD (vs upward in Marfan). Treated with pyridoxine (B6), diet and anti-thrombotic measures.
Recognise
- Marfanoid habitus (tall, arachnodactyly, pectus) WITH intellectual disability and ectopia lentis (lens dislocation — typically DOWNWARD)
- Thromboembolism (arterial and venous — a major cause of morbidity/death), osteoporosis, fair complexion
- Raised plasma/urine homocysteine
Red flags
- Thromboembolic events (stroke, DVT/PE) — especially around surgery/anaesthesia
- Lens dislocation/glaucoma
Differentials & how to tell them apart
Investigations
Plasma/urine homocysteine (raised), methionine; enzyme/genetic testing; ophthalmology (lens); newborn screening in some regions.
Management
Pyridoxine (B6); methionine-restricted diet ± betaine; thrombosis prophylaxis
- 1Confirm raised homocysteine. Trial pyridoxine (B6) — many respond; add methionine-restricted diet, betaine, folate/B12 for non-responders. Reduce thrombotic risk.Gate: Distinguish from MARFAN (downward vs upward lens dislocation, intellectual disability, and the THROMBOTIC tendency) — homocystinuria needs anti-thrombotic care and B6, not just connective-tissue management
- 2Lifelong biochemical control and thrombosis prevention (especially perioperatively); ophthalmology; genetic counselling.
Key points
Marfanoid + intellectual disability + DOWNWARD lens dislocation + thrombosis = homocystinuria (not Marfan). B6-responsive in many. The thrombotic risk is the killer.
Monitor & prognosis
Homocysteine; thrombotic events; lens/eye.
Improved with treatment; thrombosis is the main risk.
Source: BIMDG; StatPearls